We are live on
!
Find out more
Arcturus Therapeutics
ARCT
ARCT
19 hedge funds and large institutions have $5.29M invested in Arcturus Therapeutics in 2018 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
67% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 3
0.85% more ownership
Funds ownership: 10.09% → 10.94% (+0.85%)
14% less funds holding
Funds holding: 22 → 19 (-3)
45% less capital invested
Capital invested by funds: $9.58M → $5.29M (-$4.28M)
50% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 6
Holders
19
Holders Change
-3
Holders Change %
-13.64%
% of All Funds
0.42%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
5
Reduced
3
Closed
6
Calls
$2K
Puts
–
Net Calls
+$2K
Net Calls Change
-$33K
Top Buyers
Top Sellers
| 1 |
WVP
Worth Venture Partners
Fort Lee,
New Jersey
|
-$290K |
| 2 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$164K |
| 3 |
JP Morgan Chase
New York
|
-$148K |
| 4 |
Simplex Trading
Chicago,
Illinois
|
-$16.4K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$7.49K |
